Tumor necrosis factor-α-mediated threonine 435 phosphorylation of p65 nuclear factor-κB subunit in endothelial cells induces vasogenic edema and neutrophil infiltration in the rat piriform cortex following status epilepticus

Journal of Neuroinflammation

Volumn 9, Issue , 2012, Pages

  Kim, Ji Eun ^a,b   Ryu, Hea Jin ^a   Choi, Soo Young ^a   Kang, Tae Cheon ^a  

^a Hallym University   (South Korea)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Astrocyte; Blood brain barrier; Endothelium; Epilepsy; Immunohistochemistry

Indexed keywords

CELL ANTIGEN; CXCL3 CHEMOKINE; PROTEIN P55; SMI 71 ANTIGEN; THREONINE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CXCL2 CHEMOKINE; DIAGNOSTIC AGENT; ENDOTHELIAL BARRIER ANTIGEN, RAT; FLUORO JADE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEMBRANE ANTIGEN; ORGANIC COMPOUND; PILOCARPINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; ASTROCYTE; CELL LOSS; CONTROLLED STUDY; ENDOTHELIUM CELL; EPILEPTIC STATE; IMMUNOREACTIVITY; MALE; MICROGLIA; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PYRIFORM CORTEX; RAT; ANIMAL; BRAIN EDEMA; CELL COUNT; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; GENE EXPRESSION REGULATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; PREFRONTAL CORTEX; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIGENS, SURFACE; BRAIN EDEMA; CELL COUNT; CHEMOKINE CXCL2; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; INJECTIONS, INTRAVENTRICULAR; MALE; NEUTROPHIL INFILTRATION; NF-KAPPA B; ORGANIC CHEMICALS; PHOSPHORYLATION; PILOCARPINE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; STATUS EPILEPTICUS; THREONINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84855581908     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-6     Document Type: Article

References (43)

1. DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG. Epidemiology of status epilepticus. J Clin Neurophysiol 1995, 12:316-325.
2. Rice AC, DeLorenzo RJ. NMDA receptor activation during status epilepticus is required for the development of epilepsy. Brain Res 1998, 782:240-247. 10.1016/S0006-8993(97)01285-7, 9519269.
3. Stewart LS, Persinger MA. Ketamine Prevents Learning Impairment When Administered Immediately after Status Epilepticus Onset. Epilepsy Behav 2001, 2:585-591. 10.1006/ebeh.2001.0272, 12609394.
4. Gale K. Subcortical structures and pathways involved in convulsive seizure generation. J Clin Neurophysiol 1992, 9:264-277. 10.1097/00004691-199204010-00007, 1350593.
5. Sheen SH, Kim JE, Ryu HJ, Yang Y, Choi KC, Kang TC. Decrease in dystrophin expression prior to disruption of brain-blood barrier within the rat piriform cortex following status epilepticus. Brain Res 2010, 1369:173-183.
6. Turski L, Ikonomidou C, Turski WA, Bortolotto ZA, Cavalheiro EA. Review: cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse 1989, 3:154-171. 10.1002/syn.890030207, 2648633.
7. Jo SM, Ryu HJ, Kim JE, Yeo SI, Kim MJ, Choi HC, Song HK, Kang TC. Up-regulation of endothelial endothelin-1 expression prior to vasogenic edema formation in the rat piriform cortex following status epilepticus. Neurosci Lett 2011, 501:25-30. 10.1016/j.neulet.2011.06.032, 21742016.
8. Kim JE, Yeo SI, Ryu HJ, Kim MJ, Kim DS, Jo SM, Kang TC. Astroglial loss and edema formation in the rat piriform cortex and hippocampus following pilocarpine-induced status epilepticus. J Comp Neurol 2010, 518:4612-4628. 10.1002/cne.22482, 20886625.
9. Sperk G. Kainic acid seizures in the rat. Prog Neurobiol 1994, 42:1-32. 10.1016/0301-0082(94)90019-1, 7480784.
10. Nitsch C, Hubauer H. Distant blood-brain barrier opening in subfields of the rat hippocampus after intrastriatal injections of kainic acid but not ibotenic acid. Neurosci Lett 1986, 64:53-58. 10.1016/0304-3940(86)90662-2, 3960388.
11. Ates N, van Luijtelaar EL, Drinkenburg WH, Vossen JM, Coenen AM. Effects of loreclezole on epileptic activity and on EEG and behaviour in rats with absence seizures. Epilepsy Res 1992, 13:43-48. 10.1016/0920-1211(92)90006-F, 1478197.
12. Nitsch C, Suzuki R, Fujiwara K, Klatzo I. Incongruence of regional cerebral blood flow increase and blood-brain barrier opening in rabbits at the onset of seizures induced by bicuculline, methoxypyridoxine, and kainic acid. J Neurol Sci 1985, 67:67-79. 10.1016/0022-510X(85)90023-1, 3981213.
13. Cornford EM, Oldendorf WH. Epilepsy and the blood-brain barrier. Adv Neurol 1986, 44:787-812.
14. Rodgers KM, Hutchinson MR, Northcutt A, Maier SF, Watkins LR, Barth DS. The cortical innate immune response increases local neuronal excitability leading to seizures. Brain 2009, 132:2478-2486. 10.1093/brain/awp177, 2732268, 19567702.
15. Deli MA, Abrahám CS, Kataoka Y, Niwa M. Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology. Cell Mol Neurobiol 2005, 25:59-127. 10.1007/s10571-004-1377-8, 15962509.
16. Sztriha L, Joó F, Szerdahelyi P, Eck E, Koltai M. Effects of dexamethasone on brain edema induced by kainic acid seizures. Neuroscience 1986, 17:107-114. 10.1016/0306-4522(86)90229-0, 3960307.
17. Sriram K, O'Callaghan JP. Divergent roles for tumor necrosis factor-alpha in the brain. J Neuroimmune Pharmaco 2007, 2:140-153.
18. Kim JE, Ryu HJ, Kang TC. P2X7 receptor activation ameliorates CA3 neuronal damage via a tumor necrosis factor-α-mediated pathway in the rat hippocampus following status epilepticus. J Neuroinflammation 2011, 8:62. 10.1186/1742-2094-8-62, 3123566, 21631954.
19. Fotin-Mleczek M, Henkler F, Samel D, Reichwein M, Hausser A, Parmryd I, Scheurich P, Schmid JA, Wajant H. Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8. J Cell Sci 2002, 115:2757-2770.
20. Kim JE, Ryu HJ, Yeo SI, Kang TC. P2X7 receptor regulates leukocyte infiltrations in rat frontoparietal cortex following status epilepticus. J Neuroinflammation 2010, 7:65. 10.1186/1742-2094-7-65, 2964655, 20939924.
21. Hayashi M, Luo Y, Laning J, Strieter RM, Dorf ME. Production and function of monocyte chemoattractant protein-1 and other beta-chemokines in murine glial cells. J Neuroimmunol 1995, 60:143-150. 10.1016/0165-5728(95)00064-9, 7642742.
22. Otto VI, Heinzel-Pleines UE, Gloor SM, Trentz O, Kossmann T, Morganti-Kossmann MC. sICAM-1 and TNF-alpha induce MIP-2 with distinct kinetics in astrocytes and brain microvascular endothelial cells. J Neurosci Res 2000, 60:733-742. 10.1002/1097-4547(20000615)60:6<733::AID-JNR5>3.0.CO;2-X, 10861785.
23. Rhodes JK, Sharkey J, Andrews PJ. The temporal expression, cellular localization, and inhibition of the chemokines MIP-2 and MCP-1 after traumatic brain injury in the rat. J Neurotrauma 2009, 26:507-525. 10.1089/neu.2008.0686, 19210118.
24. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 1997, San Diego, Academic Press, 3.
25. Kang TC, Kim DS, Kwak SE, Kim JE, Won MH, Kim DW, Choi SY, Kwon OS. Epileptogenic roles of astroglial death and regeneration in the dentate gyrus of experimental temporal lobe epilepsy. Glia 2006, 54:258-271. 10.1002/glia.20380, 16845674.
26. Biagas KV, Uhl MW, Schiding JK, Nemoto EM, Kochanek PM. Assessment of posttraumatic polymorphonuclear leukocyte accumulation in rat brain using tissue myeloperoxidase assay and vinblastine treatment. J Neurotrauma 1992, 9:363-371. 10.1089/neu.1992.9.363, 1337917.
27. Babcock AA, Kuziel WA, Rivest S, Owens T. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J Neurosci 2003, 23:7922-7930.
28. Seiffert E, Dreier JP, Ivens S, Bechmann I, Tomkins O, Heinemann U, Friedman A. Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. J Neurosci 2004, 24:7829-7836. 10.1523/JNEUROSCI.1751-04.2004, 15356194.
29. Farkas G, Márton J, Nagy Z, Mándi Y, Takács T, Deli MA, Abrahám CS. Experimental acute pancreatitis results in increased blood-brain barrier permeability in the rat: a potential role for tumor necrosis factor and interleukin 6. Neurosci Lett 1998, 242:147-150. 10.1016/S0304-3940(98)00060-3, 9530927.
30. Viatour P, Merville MP, Bours V, Chariot A. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci 2005, 30:43-52. 10.1016/j.tibs.2004.11.009, 15653325.
31. Sternberger NH, Sternberger LA. Blood-brain barrier protein recognized by monoclonal antibody. Proc Natl Acad Sci USA 1987, 84:8169-8173. 10.1073/pnas.84.22.8169, 299500, 3500474.
32. Sternberger NH, Sternberger LA, Kies MW, Shear CR. Cell surface endothelial proteins altered in experimental allergic encephalomyelitis. J Neuroimmunol 1989, 21:241-248. 10.1016/0165-5728(89)90180-X, 2783587.
33. Perdiki M, Farooque M, Holtz A, Li GL, Olsson Y. Expression of endothelial barrier antigen immunoreactivity in blood vessels following compression trauma to rat spinal cord. Temporal evolution and relation to the degree of the impact. Acta Neuropathol 1998, 96:8-12. 10.1007/s004010050854, 9678508.
34. Krum JM, Kenyon KL, Rosenstein JM. Expression of blood-brain barrier characteristics following neuronal loss and astroglial damage after administration of anti-Thy-1 immunotoxin. Exp Neurol 1997, 146:33-45. 10.1006/exnr.1997.6528, 9225736.
35. Ghabriel MN, Zhu C, Leigh C. Electron microscope study of blood-brain barrier opening induced by immunological targeting of the endothelial barrier antigen. Brain Res 2002, 934:140-151. 10.1016/S0006-8993(02)02416-2, 11955477.
36. Lawrenson JG, Ghabriel MN, Reid AR, Gajree TN, Allt G. Differential expression of an endothelial barrier antigen between the CNS and the PNS. J Anat 1995, 186:217-221. 1167287, 7649815.
37. Rosenstein JM, Krum JM, Sternberger LA, Pulley MT, Sternberger NH. Immunocytochemical expression of the endothelial barrier antigen (EBA) during brain angiogenesis. Dev Brain Res 1992, 66:47-54.
38. Sternberger NH, Sternberger LA, Kies MW, Shear CR. Cell surface endothelial proteins altered in experimental allergic encephalomyelitis. J Neuroimmunol 1989, 21:241-248. 10.1016/0165-5728(89)90180-X, 2783587.
39. O'Shea JM, Perkins ND. Thr435 phosphorylation regulates RelA (p65) NF-kappaB subunit transactivation. Biochem J 2010, 426:345-354. 10.1042/BJ20091630, 2829238, 20001970.
40. Tinsley JM, Blake DJ, Zuellig RA, Davies KE. Increasing complexity of the dystrophin-associated protein complex. Proc Natl Acad Sci USA 1994, 91:8307-8313. 10.1073/pnas.91.18.8307, 44595, 8078878.
41. Bird TA, Schooley K, Dower SK, Hagen H, Virca GD. Activation of nuclear transcription factor NF-kappaB by interleukin-1 is accompanied by casein kinase II-mediated phosphorylation of the p65 subunit. J Biol Chem 1997, 272:32606-32612. 10.1074/jbc.272.51.32606, 9405476.
42. De Simoni MG, Perego C, Ravizza T, Moneta D, Conti M, Marchesi F, De Luigi A, Garattini S, Vezzani A. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci 2000, 12:2623-2633. 10.1046/j.1460-9568.2000.00140.x, 10947836.
43. Fuentes ME, Durham SK, Swerdel MR, Lewin AC, Barton DS, Megill JR, Bravo R, Lira SA. Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. J Immunol 1995, 155:5769-5776.